As of May 03
| -1.50 / -3.17%|
The 20 analysts offering 12-month price forecasts for Imperva Inc have a median target of 68.00, with a high estimate of 78.00 and a low estimate of 36.00. The median estimate represents a +48.18% increase from the last price of 45.89.
The current consensus among 22 polled investment analysts is to Buy stock in Imperva Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.